TMPO and neoplasm: Thymopentin (TP5), an immune-modulating peptide, may enhance the antitumour efficacy of ADV.<h4>Methods</h4>We tested TP5 combined with adenovirus type 5 in tumor models, measuring tumor growth and immune changes using flow cytometry and antibody-based cell depletion.